samedan logo
 
 
spacer
home > ebr
PUBLICATIONS

European BioPharmaceutical Review

 

European Biopharmaceutical Review (EBR) is a journal designed to fill a unique position in scientific publishing. Published quarterly, it provides a dedicated platform of communication and information for the European biopharmaceutical market across Europe, North America & the rest of the world.

With editorial consisting of in-depth articles, case studies, meeting and report reviews written by specialists with hands-on experience in the biopharmaceutical industry, traditional multi-national pharmaceutical companies, investment houses and industry-associated governmental, economic and societal bodies. Each quarterly edition examines topical areas of importance across the board of biopharmaceutical research and development, with regular feature sections on BioBusiness Development, Research and Innovation, BioDiscovery, BioManufacturing plus special focuses on geographic or therapeutic territories.

For further information please contact:

Advertising
Neil Clarke
Yvette Allen

Editorial
Danielle Levett

View the digital version of EBR

ebr
 
 
Featured in this issue
BioResearch and Innovation

Matthew Sleeman and Fabio Magrini at MedImmune review developments in using antibodies to treat autoimmune diseases and in other areas of unmet medical need, and hope that this will continue to stimulate research into the pathogenic mechanisms of autoimmunity.

BioDevelopment and Regulatory
  Discovery Technology

Technological advances have led to quantitative polymerase chain reaction (qPCR) becoming a quality validation method for a range of scientific and medical approaches. Tobias Hampshire at Thermo Fisher Scientific provides an overview of recent developments in probe-based technology.

spacer
Edited by
Dr Helen Tayton-Martin,
Chief Operating Officer,
Adaptimmune Ltd
Published quarterly in
January, April,
July and October

 

 
Industry Events

Improving Solubility

21-23 June 2010, London, UK

Consequently, Pharma IQ’s 6th Annual Improving Solubility conference taking place in London on 22nd- 23rd June with pre-conference workshops on 21st June will explore the newest solubility enhancement technologies, and the best practice strategies of their implementation to ensure efficiency from discovery to preclinical development.
More info >>

 
News and Press Releases

Almac Doubles Capacity at North Carolina Facility

The Almac Group has completed a 67,000 square foot expansion to their North Carolina facility in Durham, which now houses both the Clinical Services and Diagnostics Divisions. Almac Clinical Services first began occupancy of the additional building on the campus in February 2008 and have since added a 30,000 square foot warehouse complete with two new loading docks. Staff from Almac Diagnostics’ nearby facility in Durham have relocated to the site and are engaged in research activity across a wide-range of projects.
More info >>

air transport logo 

 

©2000-2007 Samedan Ltd.
About Us | Register | Login | Site Map | Terms and Conditions | Contact Us |
Add to favourites

Print this page

Send to a friend
Privacy statement